AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$4.70
-0.25 (-5.05%)
Open$4.92
Previous Close$4.95
Day High$5.01
Day Low$4.70
52W High$7.55
52W Low$2.93
Volume—
Avg Volume2.32M
Market Cap584.88M
P/E Ratio—
EPS$-0.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+451.1% upside
Current
$4.70
$4.70
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 50.98M | 52.14M | 128.94M |
| Net Income | -95,881,876 | -88,270,957 | 33.13M |
| Profit Margin | -188.1% | -178.7% | 25.7% |
| EBITDA | -80,684,672 | -78,406,749 | 53.66M |
| Free Cash Flow | — | — | 23.71M |
| Rev Growth | -2.2% | -2.2% | +19.1% |
| Debt/Equity | 4.68 | 4.68 | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |